Yes, cheap labor to replace tenured reps with higher base salaries. Also, on a side note, can you imagine the cost of Eisai's Unemployment Insurance (and that of other pharma companies who have done lay-off's) with all these employee terminations and impending lay-off's? It cannot be cheap. Their rates will increase.
